China might be emerging from the grip of COVID-19, but many start-ups face a long battle. This is when VCs find out who the winners are
The coronavirus outbreak inevitably crippled early- and growth-stage activity in China’s technology sector. A meager $3.1 billion was invested in the first quarter of 2020, a six-year low. By March,...
Bertelsmann India Investments has earmarked USD 500m, provided by its eponymous German parent, for investment in local start-ups. The VC unit’s total deployment since its launch in 2013 is USD 285m.
UK-headquartered incubator Entrepreneur First (EF) has raised USD 158m, targeted in part at investment in Southeast Asian start-ups and expanding its reach in the region.
CDH Investments has agreed to sell New Zealand-based supplements manufacturer The Better Health Company (TBHC) to Nestlé Health Science for an undisclosed sum.
India and Southeast Asia-focused Panthera Growth Partners has reached a first close on its second fund with commitments amounting to more than half the overall target of USD 250m.